Smart Home Healthcare Market to Accelerate, Driven by Remote Monitoring Demand
Event summary
- ABI Research forecasts smart home healthcare shipments to reach 170 million units by 2030, up from 124 million in 2026.
- This represents an 8.1% Compound Annual Growth Rate (CAGR) for the period.
- Key device categories include connected CGMs, digital scales, PERS devices, baby monitors, and blood pressure monitors.
- ResMed reported 10% YoY revenue growth in 2025, Dexcom 16% YoY, and Abbott Laboratories over 10% YoY in its Medical Devices business.
- Medical Guardian launched cellular-enabled RPM devices in April 2025, integrated with its MGEngage360 platform.
The big picture
The accelerating growth in smart home healthcare reflects a broader shift towards preventative care, aging-in-place solutions, and a desire for greater patient autonomy. Fueled by an aging global population and increasing chronic disease prevalence, the market represents a significant opportunity for device manufacturers and healthcare providers alike. The strong revenue growth reported by ResMed, Dexcom, and Abbott underscores the financial viability of this trend, but also signals intensifying competition within the space.
What we're watching
- Connectivity Shift
- While Bluetooth remains dominant due to battery life advantages, the adoption of cellular-based devices by Medical Guardian suggests a growing need for continuous, smartphone-independent monitoring, potentially impacting Bluetooth’s long-term dominance.
- Data Security
- Increased reliance on connected devices and data transmission raises concerns about patient data security and privacy, which will likely necessitate stricter regulatory oversight and cybersecurity investments.
- Integration Challenges
- The seamless integration of these devices with existing healthcare provider workflows and electronic health record (EHR) systems will be crucial for widespread adoption and will determine the true value proposition for healthcare providers.
Related topics